Alyce Hannan
Family · Metropolis, ILNPI 1073153235
Payments from drug & device makers
Across 391 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$973
- GSK$812
- Johnson & Johnson$493
- Lilly USA, LLC$426
- Novartis$407
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 55 | $1,154 |
| Novo Nordisk | 61 | $973 |
| GSK | 61 | $812 |
| Johnson & Johnson | 32 | $493 |
| Lilly USA, LLC | 22 | $426 |
| Novartis | 24 | $407 |
| Bayer | 21 | $399 |
| Amgen | 20 | $350 |
| AbbVie | 24 | $293 |
| Pfizer | 15 | $247 |
| Boehringer Ingelheim | 15 | $229 |
| Dexcom, Inc. | 7 | $126 |
| Esperion Therapeutics, Inc. | 11 | $115 |
| Merck | 6 | $96 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Grifols USA, LLC | 2 | $38 |
| Exact Sciences | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Lundbeck LLC | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Electromed, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $13 |
| Itamar Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,408 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 120 | $119,664 |
| EliquisApixaban | 98 | $103,690 |
| JardianceEmpagliflozin | 85 | $80,803 |
| MounjaroTirzepatide | 63 | $67,290 |
| RybelsusSemaglutide | 30 | $64,587 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $48,341 |
| EntrestoSacubitril/Valsartan | 39 | $35,063 |
| JanuviaSitagliptin Phosphate | 22 | $24,010 |
| FarxigaDapagliflozin Propanediol | 33 | $23,817 |
| Repatha SureclickEvolocumab | 32 | $21,950 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 27 | $20,879 |
| XareltoRivaroxaban | 15 | $17,171 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $15,677 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 578 | $9,568 |
| BrilintaTicagrelor | 13 | $8,400 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $973 | $184,250150 claims |
| PfizerEliquis | $247 | $103,69098 claims |
| Boehringer IngelheimJardiance | $229 | $80,80385 claims |
| Lilly USA, LLCMounjaro | $426 | $67,29063 claims |
| GSKTrelegy Ellipta | $812 | $48,34167 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $1,154 | $47,89469 claims |
| NovartisEntresto | $407 | $35,06339 claims |
| MerckJanuvia | $96 | $24,01022 claims |
| Johnson & JohnsonXarelto | $493 | $17,17115 claims |
| AbbVieSynthroid | $293 | $99431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Metropolis
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.